Gold(i) complexes of water-soluble diphos-type ligands: Synthesis, anticancer activity, apoptosis and thioredoxin reductase inhibition

Anticancer gold(i)–phosphine complexes as potent autophagy-inducing agents

(2011) Songhai Tian et al.   CHEMICAL COMMUNICATIONS

Bioinorganic and medicinal chemistry: aspects of gold(i)-protein complexes

(2011) Krishna P. Bhabak et al.   DALTON TRANSACTIONS

Disruption of the mitochondrial thioredoxin system as a cell death mechanism of cationic triphenylmethanes

(2011) Xu Zhang et al.   FREE RADICAL BIOLOGY AND MEDICINE

Approaches for targeting mitochondria in cancer therapy

(2010) Gerard G.M. D'Souza et al.   BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS

Gold(i) complex of N,N′-disubstituted cyclic thiourea with in vitro and in vivo anticancer properties—potent tight-binding inhibition of thioredoxin reductase

(2010) Kun Yan et al.   CHEMICAL COMMUNICATIONS

Benzimidazol-2-ylidene Gold(I) Complexes Are Thioredoxin Reductase Inhibitors with Multiple Antitumor Properties

(2010) Riccardo Rubbiani et al.   JOURNAL OF MEDICINAL CHEMISTRY

Novel multitopic diphos-type ligands.

(2010) Peter C. Kunz et al.   JOURNAL OF ORGANOMETALLIC CHEMISTRY

The Design of Gold-Based, Mitochondria-Targeted Chemotherapeutics

(2009) Susan J. Berners-Price et al.   AUSTRALIAN JOURNAL OF CHEMISTRY

Cancer cell death induced by phosphine gold(I) compounds targeting thioredoxin reductase

(2009) Valentina Gandin et al.   BIOCHEMICAL PHARMACOLOGY

Platinum Drug Distribution in Cancer Cells and Tumors

(2009) Alice V. Klein et al.   CHEMICAL REVIEWS

Anticancer Therapeutics That Target Selenoenzymes: Synthesis, Characterization, in vitro Cytotoxicity, and Thioredoxin Reductase Inhibition of a Series of Gold(I) Complexes Containing Hydrophilic Phosphine Ligands

(2009) Elena Vergara et al.   ChemMedChem

On the medicinal chemistry of gold complexes as anticancer drugs

(2009) Ingo Ott   COORDINATION CHEMISTRY REVIEWS

Thioredoxin reductase: A target for gold compounds acting as potential anticancer drugs

(2009) Alberto Bindoli et al.   COORDINATION CHEMISTRY REVIEWS

Imidazole-based phosphane gold(I) complexes as potential agents for cancer treatment: Synthesis, structural studies and antitumour activity

(2009) Peter C. Kunz et al.   DALTON TRANSACTIONS

Auranofin disrupts selenium metabolism in Clostridium difficile by forming a stable Au–Se adduct

(2009) Sarah Jackson-Rosario et al.   JOURNAL OF BIOLOGICAL INORGANIC CHEMISTRY

Targeting selenium metabolism and selenoproteins: Novel avenues for drug discovery

(2009) Sarah Elizabeth Jackson-Rosario et al.   Metallomics

In Vitro Antitumor Activity of the Water Soluble Copper(I) Complexes Bearing the Tris(hydroxymethyl)phosphine Ligand

(2008) Cristina Marzano et al.   JOURNAL OF MEDICINAL CHEMISTRY

Mitochondria-Targeted Chemotherapeutics: The Rational Design of Gold(I)N-Heterocyclic Carbene Complexes That Are Selectively Toxic to Cancer Cells and Target Protein Selenols in Preference to Thiols

(2008) James L. Hickey et al.   JOURNAL OF THE AMERICAN CHEMICAL SOCIETY

Zirconium Complexes Containing Tetradentate O,P,P,O Ligands: Ethylene and Propylene Polymerization Studies

(2008) Richard J. Long et al.   ORGANOMETALLICS

Mitochondrial Medicine: Pharmacological targeting of mitochondria in disease

(2007) J S Armstrong   BRITISH JOURNAL OF PHARMACOLOGY